EGCG analogs activate AMPK, leading in inhibition of cell proliferation, up-regulation of the cyclin-dependent kinase inhibitor p21, downregulation of the mTOR pathway, and suppression of stem cell population in human breast cancer cells. The gene discussed is MTOR; the disease is breast carcinoma.